Clinical trial
V260 Registration Study (V260-013)(COMPLETED)
NCT00166517 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00166517 |
|---|---|
| Title | V260 Registration Study (V260-013)(COMPLETED) |
| Official title | Immunogenicity and Safety of V260 in Healthy Infants in Korea |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rotavirus |
| Intervention type | Biological |
| Interventions | Rotavirus Vaccine, Live, Oral, Pentavalent, Comparator: Placebo |
| Enrollment | 178 |
| Start date | Aug 1, 2005 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Sep 14, 2005 |
| Last update posted | Apr 1, 2015 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: